Stock Research: Convatec Group

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Convatec Group

LSE:CTEC GB00BD3VFW73
65
  • Value
    64
  • Growth
    25
  • Safety
    Safety
    27
  • Combined
    15
  • Sentiment
    98
  • 360° View
    360° View
    65
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Convatec Group Plc is a medical products and technologies company. It operates in the medical products and technologies industry, with a focus on solutions for chronic conditions, including Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. The company markets and sells its solutions and services globally. In the last fiscal year, the company had a market cap of $6,659 million, profits of $1,299 million, and revenue of $2,289 million with 10,483 employees.

more
Index
FTSE All Shares
FTSE 250
FTSE 350
Human Rights
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
64 60 53 87
Growth
25 10 29 7
Safety
Safety
27 19 8 39
Sentiment
98 80 85 66
360° View
360° View
65 32 30 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
89 75 82 38
Opinions Change
81 53 46 50
Pro Holdings
n/a 92 54 90
Market Pulse
79 51 74 40
Sentiment
98 80 85 66
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
64 60 53 87
Growth
25 10 29 7
Safety Safety
27 19 8 39
Combined
15 1 10 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
64 56 50 78
Price vs. Earnings (P/E)
48 49 48 78
Price vs. Book (P/B)
22 22 16 73
Dividend Yield
79 75 74 65
Value
64 60 53 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
28 4 26 17
Profit Growth
62 45 52 16
Capital Growth
19 25 16 34
Stock Returns
53 54 65 25
Growth
25 10 29 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
28 23 26 18
Refinancing
35 34 23 69
Liquidity
29 32 28 33
Safety Safety
27 19 8 39

Similar Stocks

Discover high‑ranked alternatives to Convatec Group and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Quilter

LSE:QLT
Country: United Kingdom
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Carl Zeiss Meditec

XTRA:AFX
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

With good value and positive sentiment, but low growth and risky financing, this combination is generally dangerous as debt requires growth to sustain it. Only investors with a strong belief in future growth potential and a high-risk tolerance should consider this stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: